Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort-Reference-Cited by-同舟云学术

Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort

Published:2022-07 Issue:7 Volume:28 Page:766-777
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Roy Anuja¹,Peterson Andrew²,Marchant Nick¹,Alvir Jose¹,Bhambri Rahul¹,Bredl Zach³,Benjumea Darrin⁴,Kemner Jason¹,Parasuraman Bhash¹

Affiliation:

1. Pfizer Inc, New York, NY.

2. Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA.

3. Care Journey, Arlington, VA.

4. Genesis Research, Hoboken, NJ.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference47 articles.

1. Transthyretin Amyloid Cardiomyopathy

2. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

3. Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy

4. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From transthyretin cardiac amyloidosis diagnosis to tafamidis treatment: Association of drop-off with patient sociodemographic characteristics;American Journal of Health-System Pharmacy;2024-07-04

2. Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan;ESC Heart Failure;2024-05-23

3. Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis;eClinicalMedicine;2023-09

4. Amyloid Screening and Treatment Drop Off in Patients with Left Ventricular Hypertrophy: Associations with Patient Socio-demographic Characteristics;2023-05-28